Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced a ...
The Society for Immunotherapy of Cancer (SITC) received an incredible number of abstract submissions in 2025, more than 1,300, including many clinical based Late-breaking Abstracts. SITC is proud to ...
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, ...
Leading healthcare data abstraction company evolves brand to better represent comprehensive clinical registry expertise across all medical specialties. While we built our reputation on exceptional ...
Nashville, Tenn.-based Vanderbilt University Medical Center has received a $2 million federal grant to expand deployment of an AI-powered data ...
SAN FRANCISCO, Feb. 11, 2025 /PRNewswire/ -- The vast majority of clinical data abstractors believe AI would save them time, effort and cost, but concerns about data quality without human oversight ...
The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback